Literature DB >> 16470373

[Lucio phenomenon. Vasculitis or occlusive vasculopathy?].

L Azulay-Abulafia1, L Pereira Spinelli, D Hardmann, B Kawa Kac, R A Levy, C Talhari, T Ruzicka.   

Abstract

Lucio's phenomenon (LP) occurs in patients with Lucio leprosy (LuL). Some interpret the cutaneous lesions and their histopathology as a thrombotic/occlusive condition, while others consider it leukocytoclastic vasculitis. The clinical similarities between the cutaneous manifestations of LP and antiphospholipid syndrome (APS) led us to investigate the relationship between these two pathological conditions. We studied the clinical, laboratory and histopathologic aspects of LuL and LP in one patient and compare these results to APS. The examination of antiphospholipid antibodies showed positive anticardiolipin (aCL) and lupus anticoagulant (LAC). The histopathological slides of cutaneous biopsies were stained by hematoxylin-eosin and Fite-Faraco. They showed the typical features of LuL, as well as thrombi, endothelial proliferation, vessel wall thickening and obliteration of the lumen. Leukocytoclastic vasculitis was not found. The clinical pattern of LuL in our case is identical to that described by Lucio and Latapi. The necrotic lesions of LP in our patient resembled APS. This suggests that LP could be considered APS secondary to LuL. Multidrug treatment for multibacillary patients (MDT-MP) was successful, with no need for thalidomide or systemic corticosteroids.

Entities:  

Mesh:

Year:  2006        PMID: 16470373     DOI: 10.1007/s00105-005-1086-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  8 in total

1.  The Lucio-Alvarado form of leprosy. A case observed in Brazil.

Authors:  T A FURTADO
Journal:  Int J Lepr       Date:  1959 Apr-Jun

Review 2.  Antiphospholipid syndrome and the skin.

Authors:  G E Gibson; W P Su; M R Pittelkow
Journal:  J Am Acad Dermatol       Date:  1997-06       Impact factor: 11.527

3.  [Not Available].

Authors:  F LATAPI
Journal:  Int J Lepr       Date:  1948 Apr-Jun

Review 4.  Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort.

Authors:  J T Lie
Journal:  Lupus       Date:  1996-10       Impact factor: 2.911

5.  The antiphospholipid syndrome.

Authors:  G R Hughes
Journal:  Lupus       Date:  1996-10       Impact factor: 2.911

Review 6.  1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a "mission impossible'?

Authors:  J C Piette
Journal:  Lupus       Date:  1996-10       Impact factor: 2.911

7.  [The lipoid reaction, a new larger concept in medicine].

Authors:  R D Azulay
Journal:  Z Hautkr       Date:  1975-01-01

8.  The "Lucio phenomenon" in diffuse leprosy.

Authors:  R S Donner; J A Shively
Journal:  Ann Intern Med       Date:  1967-10       Impact factor: 25.391

  8 in total
  4 in total

1.  Lepromatous leprosy mimicking systemic lupus erythematosus: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.

Authors:  Asli Karadeniz; Lindsay Lally; Cynthia Magro; Roger Levy; Doruk Erkan; Michael D Lockshin
Journal:  HSS J       Date:  2014-08-27

2.  The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico.

Authors:  Xiang Y Han; Kurt Clement Sizer; Jesús S Velarde-Félix; Luis O Frias-Castro; Francisco Vargas-Ocampo
Journal:  Int J Dermatol       Date:  2012-08       Impact factor: 2.736

Review 3.  Systematic review of case reports of antiphospholipid syndrome following infection.

Authors:  N Abdel-Wahab; M A Lopez-Olivo; G P Pinto-Patarroyo; M E Suarez-Almazor
Journal:  Lupus       Date:  2016-04-07       Impact factor: 2.911

4.  Lucio's phenomenon, an uncommon occurrence among leprosy patients in Sri Lanka.

Authors:  Sandamalee Herath; Mitrakrishnan Rayno Navinan; Isurujith Liyanage; Nadeesha Rathnayaka; Jevon Yudhishdran; Janakie Fernando; Ganga Sirimanne; Aruna Kulatunga
Journal:  BMC Res Notes       Date:  2015-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.